Month-over-month ADM prescribing increased in January, remained stable in February, and increased again in March 2026
Your health history, your goals, and how your body responds to treatment all play a role in what your provider may recommend
A 2021 review confirmed no clinical trials targeting NNMT had been reported [5], and MOTS-c likewise has no large human efficacy trial proving it works as a fat-loss therapy
An effective alternative to expensive injections, it naturally increases GLP-1 (glucagon-like peptide-1) hormone levels to reduce appetite, curb cravings &
NICE guidance requires specialist initiation, specific BMI criteria, weight-related comorbidities, and treatment as part of comprehensive lifestyle programmes
It's a reason to ask your doctor about a musculoskeletal protection plan